Live Stocks are rallying as Trump eased fears over China tariffs and Powell. See the latest. Cboe UK • EUR Reply S.p.A. (REYM.XC) Follow Add holdings 147.25 0.00 (0.00%) At close: April 14 at 4:18:03 PM GMT+1 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for REYM.XC 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: REYM.XC View More All News Press Releases SEC Filings REPLY S.p.A.: Shareholders’ Meeting Approves the 2024 Financial Statements Uniserve Partners with Logistics Reply to Deliver Transformation to Customers Supply Chains Go Reply Awarded 2025 Partner of the Year for Country – UK/IE by Google Cloud A New Era in Design: Generative AI and Interdisciplinary Creative Synergy between Reply, ACPV ARCHITECTS, and Marazzi Reply Doubles its AI-based International Competitions: Introducing the Reply AI Music Contest and Welcoming Back the Reply AI Film Festival Reply and AWS Announce Multi-Year Strategic Collaboration to Advance Generative AI Innovations, Helping Customers Design, Develop, and Deploy Scalable and Secure AI Applications Solidsoft Reply Successfully Integrates the Hellenic Medicines Verification System into the European Medicines Verification Platform Reply at NVIDIA GTC 2025: How AI Agents and Digital Humans are Redefining Customer Experience REPLY: The Board of Directors Approved the Draft Financial Statements for the Year 2024 REPLY: Logistics Reply Optimises Delivery Times for More Nutrition and ESN with LEA Reply REPLY: Go Reply and Sprint Reply Automate the Creation of Clinical Study Reports for Dr. Willmar Schwabe with AI